Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 320

1.

Doxycycline prophylaxis for bacterial sexually transmitted infections.

Grant JS, Stafylis C, Celum C, Grennan T, Haire B, Kaldor J, Luetkemeyer AF, Saunders JM, Molina JM, Klausner JD.

Clin Infect Dis. 2019 Sep 1. pii: ciz866. doi: 10.1093/cid/ciz866. [Epub ahead of print]

PMID:
31504345
2.

Pre-exposure prophylaxis differentially alters circulating and mucosal immune cell activation in HSV-2 seropositive women.

Richert-Spuhler LE, Pattacini L, Plews M, Irungu E, Muwonge TR, Katabira E, Mugo N, Meyers AFA, Celum C, Baeten JM, Lingappa JR, Lund JM.

AIDS. 2019 Jul 22. doi: 10.1097/QAD.0000000000002323. [Epub ahead of print]

PMID:
31335802
3.

HIV pre-exposure prophylaxis for adolescent girls and young women in Africa: from efficacy trials to delivery.

Celum CL, Delany-Moretlwe S, Baeten JM, van der Straten A, Hosek S, Bukusi EA, McConnell M, Barnabas RV, Bekker LG.

J Int AIDS Soc. 2019 Jul;22 Suppl 4:e25298. doi: 10.1002/jia2.25298.

4.

Ethical considerations for new HIV prevention trials.

Sugarman J, Celum CL, Donnell D, Mayer KH.

Lancet HIV. 2019 Aug;6(8):e489-e491. doi: 10.1016/S2352-3018(19)30184-5. Epub 2019 Jun 17. No abstract available.

PMID:
31221591
5.

Perceptions of pregnancy occurring among HIV-serodiscordant couples in Kenya.

Kimemia G, Ngure K, Baeten JM, Celum C, Dew K, Njuguna N, Mugo N, Heffron R.

Reprod Health. 2019 Jun 18;16(1):85. doi: 10.1186/s12978-019-0751-4.

6.

The Incremental Cost of Delivering PrEP as a Bridge to ART for HIV Serodiscordant Couples in Public HIV Care Clinics in Kenya.

Irungu EM, Sharma M, Maronga C, Mugo N, Ngure K, Celum C, Barnabas RV, Baeten J, Heffron R.

AIDS Res Treat. 2019 May 2;2019:4170615. doi: 10.1155/2019/4170615. eCollection 2019.

7.

Tenofovir-Diphosphate as a Marker of HIV Pre-exposure Prophylaxis Use Among East African Men and Women.

Pyra M, Anderson P, Haberer JE, Heffron R, Celum C, Asiimwe S, Katabira E, Mugo NR, Bukusi EA, Baeten JM.

Front Pharmacol. 2019 Apr 17;10:401. doi: 10.3389/fphar.2019.00401. eCollection 2019.

8.

Comparisons of Human Immunodeficiency Virus Type 1 Envelope Variants in Blood and Genital Fluids near the Time of Male-to-Female Transmission.

Williams-Wietzikoski CA, Campbell MS, Payant R, Lam A, Zhao H, Huang H, Wald A, Stevens W, Gray G, Farquhar C, Rees H, Celum C, Mullins JI, Lingappa JR, Frenkel LM.

J Virol. 2019 Jun 14;93(13). pii: e01769-18. doi: 10.1128/JVI.01769-18. Print 2019 Jul 1.

PMID:
30996101
9.

A clinic-based tablet application to support safer conception among HIV serodiscordant couples in Kenya: feasibility and acceptability study.

Velloza J, Ngure K, Kiptinness C, Quame-Amaglo J, Thuo N, Dew K, Kimani M, Gakuo S, Unger JA, Kolko B, Baeten JM, Celum C, Mugo N, Heffron R.

Mhealth. 2019 Feb 14;5:4. doi: 10.21037/mhealth.2019.01.04. eCollection 2019.

10.

Implementation of a comprehensive safer conception intervention for HIV-serodiscordant couples in Kenya: uptake, use and effectiveness.

Heffron R, Ngure K, Velloza J, Kiptinness C, Quame-Amalgo J, Oluch L, Thuo N, Njoroge J, Momanyi R, Gakuo S, Mbugua S, Morrison S, Haugen H, Chohan B, Celum C, Baeten JM, Mugo N.

J Int AIDS Soc. 2019 Apr;22(4):e25261. doi: 10.1002/jia2.25261.

11.

Validation of clinic-based cryptococcal antigen lateral flow assay screening in HIV-infected adults in South Africa.

Drain PK, Hong T, Krows M, Govere S, Thulare H, Wallis CL, Gosnell BI, Moosa MY, Bassett IV, Celum C.

Sci Rep. 2019 Feb 25;9(1):2687. doi: 10.1038/s41598-018-37478-7.

12.

Correction: Whole genome sequencing of extreme phenotypes identifies variants in CD101 and UBE2V1 associated with increased risk of sexually acquired HIV-1.

Mackelprang RD, Bamshad MJ, Chong JX, Hou X, Buckingham KJ, Shively K, deBruyn G, Mugo NR, Mullins JI, McElrath MJ, Baeten JM, Celum C, Emond MJ, Lingappa JR; Partners in Prevention HSV/HIV Transmission Study and the Partners PrEP Study Teams.

PLoS Pathog. 2019 Feb 11;15(2):e1007588. doi: 10.1371/journal.ppat.1007588. eCollection 2019 Feb.

13.

Integrating hypertension screening at the time of voluntary HIV testing among adults in South Africa.

Drain PK, Hong T, Hajat A, Krows M, Govere S, Thulare H, Moosa MYS, Bassett I, Celum C.

PLoS One. 2019 Feb 8;14(2):e0210161. doi: 10.1371/journal.pone.0210161. eCollection 2019.

14.

Beyond HIV prevention: everyday life priorities and demand for PrEP among Ugandan HIV serodiscordant couples.

Nakku-Joloba E, Pisarski EE, Wyatt MA, Muwonge TR, Asiimwe S, Celum CL, Baeten JM, Katabira ET, Ware NC.

J Int AIDS Soc. 2019 Jan;22(1):e25225. doi: 10.1002/jia2.25225.

15.

Reaching the 90-90-90 target: lessons from HIV self-testing.

Celum C, Barnabas R.

Lancet HIV. 2019 Feb;6(2):e68-e69. doi: 10.1016/S2352-3018(18)30289-3. Epub 2018 Dec 21. No abstract available.

16.

Quadrivalent HPV vaccine in HIV-1-infected early adolescent girls and boys in Kenya: Month 7 and 12 post vaccine immunogenicity and correlation with immune status.

Mugo NR, Eckert L, Magaret AS, Cheng A, Mwaniki L, Ngure K, Celum C, Baeten JM, Galloway DA, Wamalwa D, Wald A.

Vaccine. 2018 Nov 12;36(46):7025-7032. doi: 10.1016/j.vaccine.2018.09.059. Epub 2018 Oct 5.

PMID:
30297124
17.

Effect of Depression on Adherence to Oral PrEP Among Men and Women in East Africa.

Velloza J, Baeten JM, Haberer J, Ngure K, Irungu E, Mugo NR, Celum C, Heffron R; Partners Demonstration Project Team.

J Acquir Immune Defic Syndr. 2018 Nov 1;79(3):330-338. doi: 10.1097/QAI.0000000000001821.

18.

HIV-Uninfected Kenyan Adolescent and Young Women Share Perspectives on Using Preexposure Prophylaxis During Pregnancy.

Pintye J, Beima-Sofie KM, Makabong'O PA, Njoroge A, Trinidad SB, Heffron RA, Baeten JM, Celum C, Matemo D, Kinuthia J, Kelley MC, John-Stewart GC.

AIDS Patient Care STDS. 2018 Jul 23. doi: 10.1089/apc.2018.0058. [Epub ahead of print]

PMID:
30036072
19.

Patterns of Oral PrEP Adherence and HIV Risk Among Eastern African Women in HIV Serodiscordant Partnerships.

Pyra M, Brown ER, Haberer JE, Heffron R, Celum C, Bukusi EA, Asiimwe S, Katabira E, Mugo NR, Baeten JM; Partners Demonstration Project Team.

AIDS Behav. 2018 Nov;22(11):3718-3725. doi: 10.1007/s10461-018-2221-3.

PMID:
30006791
20.

Pregnancy outcomes and infant growth among babies with in-utero exposure to tenofovir-based preexposure prophylaxis for HIV prevention.

Heffron R, Mugo N, Hong T, Celum C, Marzinke MA, Ngure K, Asiimwe S, Katabira E, Bukusi EA, Odoyo J, Tindimwebwa E, Bulya N, Baeten JM; Partners Demonstration Project and the Partners PrEP Study Teams.

AIDS. 2018 Jul;32(12):1707-1713. doi: 10.1097/QAD.0000000000001867.

21.

Tenofovir and tenofovir-diphosphate concentrations during pregnancy among HIV-uninfected women using oral preexposure prophylaxis.

Pyra M, Anderson PL, Hendrix CW, Heffron R, Mugwanya K, Haberer JE, Thomas KK, Celum C, Donnell D, Marzinke MA, Bukusi EA, Mugo NR, Asiimwe S, Katabira E, Baeten JM; Partners Demonstration Study Team.

AIDS. 2018 Aug 24;32(13):1891-1898. doi: 10.1097/QAD.0000000000001922.

22.

Messaging Circumstances and Economic Pressures as Influences on Linkage to Medical Male Circumcision following Community-Based HIV Testing for Men in Rural Southwest Uganda: A Qualitative Study.

Gilbert HN, Wyatt MA, Asiimwe S, Turyamureeba B, Tumwesigye E, Van Rooyen H, Barnabas RV, Celum CL, Ware NC.

AIDS Res Treat. 2018 May 3;2018:8387436. doi: 10.1155/2018/8387436. eCollection 2018.

23.

Integrated delivery of antiretroviral treatment and pre-exposure prophylaxis to HIV-1 serodiscordant couples in East Africa: a qualitative evaluation study in Uganda.

Ware NC, Pisarski EE, Nakku-Joloba E, Wyatt MA, Muwonge TR, Turyameeba B, Asiimwe SB, Heffron RA, Baeten JM, Celum CL, Katabira ET.

J Int AIDS Soc. 2018 May;21(5):e25113. doi: 10.1002/jia2.25113.

24.

C-reactive protein as a screening test for HIV-associated pulmonary tuberculosis prior to antiretroviral therapy in South Africa.

Shapiro AE, Hong T, Govere S, Thulare H, Moosa MY, Dorasamy A, Wallis CL, Celum CL, Grosset J, Drain PK.

AIDS. 2018 Aug 24;32(13):1811-1820. doi: 10.1097/QAD.0000000000001902.

25.

Cost of Integrating Noncommunicable Disease Screening Into Home-Based HIV Testing and Counseling in South Africa.

Golovaty I, Sharma M, Van Heerden A, van Rooyen H, Baeten JM, Celum C, Barnabas RV.

J Acquir Immune Defic Syndr. 2018 Aug 15;78(5):522-526. doi: 10.1097/QAI.0000000000001713.

26.

Depression and Anxiety as Risk Factors for Delayed Care-Seeking Behavior in Human Immunodeficiency Virus-Infected Individuals in South Africa.

Rane MS, Hong T, Govere S, Thulare H, Moosa MY, Celum C, Drain PK.

Clin Infect Dis. 2018 Oct 15;67(9):1411-1418. doi: 10.1093/cid/ciy309.

PMID:
29659757
27.

Increased Risk of HIV Acquisition Among Women Throughout Pregnancy and During the Postpartum Period: A Prospective Per-Coital-Act Analysis Among Women With HIV-Infected Partners.

Thomson KA, Hughes J, Baeten JM, John-Stewart G, Celum C, Cohen CR, Ngure K, Kiarie J, Mugo N, Heffron R; Partners in Prevention HSV/HIV Transmission Study and Partners PrEP Study Teams.

J Infect Dis. 2018 Jun 5;218(1):16-25. doi: 10.1093/infdis/jiy113.

28.

Identification and validation of a multi-assay algorithm for cross-sectional HIV incidence estimation in populations with subtype C infection.

Laeyendecker O, Konikoff J, Morrison DE, Brookmeyer R, Wang J, Celum C, Morrison CS, Abdool Karim Q, Pettifor AE, Eshleman SH.

J Int AIDS Soc. 2018 Feb;21(2). doi: 10.1002/jia2.25082.

29.

Safer conception among HIV-1 serodiscordant couples in East Africa: understanding knowledge, attitudes, and experiences.

Hancuch K, Baeten J, Ngure K, Celum C, Mugo N, Tindimwebwa E, Heffron R; Partners Demonstration Project Team.

AIDS Care. 2018 Aug;30(8):973-981. doi: 10.1080/09540121.2018.1437251. Epub 2018 Feb 17.

30.

Motivated Reasoning and HIV Risk? Views on Relationships, Trust, and Risk from Young Women in Cape Town, South Africa, and Implications for Oral PrEP.

Hartmann M, McConnell M, Bekker LG, Celum C, Bennie T, Zuma J, van der Straten A.

AIDS Behav. 2018 Nov;22(11):3468-3479. doi: 10.1007/s10461-018-2044-2.

PMID:
29404757
31.

Evaluation of the association between the concentrations of key vaginal bacteria and the increased risk of HIV acquisition in African women from five cohorts: a nested case-control study.

McClelland RS, Lingappa JR, Srinivasan S, Kinuthia J, John-Stewart GC, Jaoko W, Richardson BA, Yuhas K, Fiedler TL, Mandaliya KN, Munch MM, Mugo NR, Cohen CR, Baeten JM, Celum C, Overbaugh J, Fredricks DN.

Lancet Infect Dis. 2018 May;18(5):554-564. doi: 10.1016/S1473-3099(18)30058-6. Epub 2018 Jan 26.

32.

Completion of the tuberculosis care cascade in a community-based HIV linkage-to-care study in South Africa and Uganda.

Shapiro AE, van Heerden A, Schaafsma TT, Hughes JP, Baeten JM, van Rooyen H, Tumwesigye E, Celum CL, Barnabas RV.

J Int AIDS Soc. 2018 Jan;21(1). doi: 10.1002/jia2.25065.

33.

Pre-exposure prophylaxis for HIV-negative persons with partners living with HIV: uptake, use, and effectiveness in an open-label demonstration project in East Africa.

Heffron R, Ngure K, Odoyo J, Bulya N, Tindimwebwa E, Hong T, Kidoguchi L, Donnell D, Mugo NR, Bukusi EA, Katabira E, Asiimwe S, Morton J, Morrison S, Haugen H, Mujugira A, Haberer JE, Ware NC, Wyatt MA, Marzinke MA, Frenkel LM, Celum C, Baeten JM; Partners Demonstration Project Team.

Gates Open Res. 2017 Nov 6;1:3. doi: 10.12688/gatesopenres.12752.1.

34.

Dual-strain genital herpes simplex virus type 2 (HSV-2) infection in the US, Peru, and 8 countries in sub-Saharan Africa: A nested cross-sectional viral genotyping study.

Johnston C, Magaret A, Roychoudhury P, Greninger AL, Reeves D, Schiffer J, Jerome KR, Sather C, Diem K, Lingappa JR, Celum C, Koelle DM, Wald A.

PLoS Med. 2017 Dec 27;14(12):e1002475. doi: 10.1371/journal.pmed.1002475. eCollection 2017 Dec.

35.

Modeling HIV disease progression and transmission at population-level: The potential impact of modifying disease progression in HIV treatment programs.

Ross JM, Ying R, Celum CL, Baeten JM, Thomas KK, Murnane PM, van Rooyen H, Hughes JP, Barnabas RV.

Epidemics. 2018 Jun;23:34-41. doi: 10.1016/j.epidem.2017.12.001. Epub 2017 Dec 5.

36.

Closing the gaps in the HIV care continuum.

Barnabas RV, Celum C.

PLoS Med. 2017 Nov 21;14(11):e1002443. doi: 10.1371/journal.pmed.1002443. eCollection 2017 Nov. Review.

37.

Brief Report: Frequency of Monitoring Kidney Function in HIV-Uninfected Persons Using Daily Oral Tenofovir Disoproxil Fumarate Pre-exposure Prophylaxis.

Mugwanya KK, Baeten JM, Wyatt C, Mugo NR, Celum CL, Ronald A, Kiarie J, Katabira E, Heffron R; Partners PrEP Study and Partners Demonstration Project Teams.

J Acquir Immune Defic Syndr. 2018 Feb 1;77(2):206-211. doi: 10.1097/QAI.0000000000001575.

38.

Whole genome sequencing of extreme phenotypes identifies variants in CD101 and UBE2V1 associated with increased risk of sexually acquired HIV-1.

Mackelprang RD, Bamshad MJ, Chong JX, Hou X, Buckingham KJ, Shively K, deBruyn G, Mugo NR, Mullins JI, McElrath MJ, Baeten JM, Celum C, Emond MJ, Lingappa JR; Partners in Prevention HSV/HIV Transmission Study and the Partners PrEP Study Teams.

PLoS Pathog. 2017 Nov 6;13(11):e1006703. doi: 10.1371/journal.ppat.1006703. eCollection 2017 Nov. Erratum in: PLoS Pathog. 2019 Feb 11;15(2):e1007588.

39.

Intimate Partner Violence and Self-Reported Pre-exposure Prophylaxis Interruptions Among HIV-Negative Partners in HIV Serodiscordant Couples in Kenya and Uganda.

Cabral A, M Baeten J, Ngure K, Velloza J, Odoyo J, E Haberer J, Celum C, Muwonge T, Asiimwe S, Heffron R; Partners Demonstration Project Team.

J Acquir Immune Defic Syndr. 2018 Feb 1;77(2):154-159. doi: 10.1097/QAI.0000000000001574.

40.

High prevalence of HIV and non-communicable disease (NCD) risk factors in rural KwaZulu-Natal, South Africa.

van Heerden A, Barnabas RV, Norris SA, Micklesfield LK, van Rooyen H, Celum C.

J Int AIDS Soc. 2017 Oct;20(2). doi: 10.1002/jia2.25012.

41.

Maternal Tenofovir Disoproxil Fumarate Use During Pregnancy Is Not Associated With Adverse Perinatal Outcomes Among HIV-infected East African Women: A Prospective Study.

Pintye J, Baeten JM, Celum C, Mugo N, Ngure K, Were E, Bukusi EA, John-Stewart G, Heffron RA.

J Infect Dis. 2017 Dec 19;216(12):1561-1568. doi: 10.1093/infdis/jix542.

42.

Brief Report: PrEP Use During Periods of HIV Risk Among East African Women in Serodiscordant Relationships.

Pyra M, Haberer JE, Heffron R, Kidoguchi L, Brown ER, Bukusi EA, Asiimwe S, Celum C, Katabira E, Mugo NR, Baeten JM; Partners Demonstration Project Team.

J Acquir Immune Defic Syndr. 2018 Jan 1;77(1):41-45. doi: 10.1097/QAI.0000000000001561.

43.

Protocol for a randomised controlled implementation trial of point-of-care viral load testing and task shifting: the Simplifying HIV TREAtment and Monitoring (STREAM) study.

Dorward J, Garrett N, Quame-Amaglo J, Samsunder N, Ngobese H, Ngomane N, Moodley P, Mlisana K, Schaafsma T, Donnell D, Barnabas R, Naidoo K, Abdool Karim S, Celum C, Drain PK.

BMJ Open. 2017 Sep 27;7(9):e017507. doi: 10.1136/bmjopen-2017-017507.

44.

Brief Report: Context Matters: PrEP Adherence is Associated With Sexual Behavior Among HIV Serodiscordant Couples in East Africa.

Haberer JE, Ngure K, Muwonge T, Mugo N, Katabira E, Heffron R, Musinguzi N, Bangsberg DR, Celum C, Baeten JM; Partners Mobile Adherence to PrEP (PMAP) Team.

J Acquir Immune Defic Syndr. 2017 Dec 15;76(5):488-492. doi: 10.1097/QAI.0000000000001548.

45.

High levels of viral suppression among East African HIV-infected women and men in serodiscordant partnerships initiating antiretroviral therapy with high CD4 counts and during pregnancy.

Mujugira A, Baeten J, Kidoguchi L, Haberer J, Celum C, Donnell D, Ngure K, Bukusi E, Mugo N, Asiimwe S, Odoyo J, Tindimwebwa E, Bulya N, Katabira E, Heffron R.

AIDS Res Hum Retroviruses. 2018 Feb;34(2):140-147. Epub 2017 Sep 13.

46.

Fertility Intentions, Pregnancy, and Use of PrEP and ART for Safer Conception Among East African HIV Serodiscordant Couples.

Heffron R, Thomson K, Celum C, Haberer J, Ngure K, Mugo N, Bukusi E, Katabira E, Odoyo J, Bulya N, Asiimwe S, Tindimwebwa E, Baeten JM; Partners Demonstration Project Team.

AIDS Behav. 2018 Jun;22(6):1758-1765. doi: 10.1007/s10461-017-1902-7.

47.

Alignment of adherence and risk for HIV acquisition in a demonstration project of pre-exposure prophylaxis among HIV serodiscordant couples in Kenya and Uganda: a prospective analysis of prevention-effective adherence.

Haberer JE, Kidoguchi L, Heffron R, Mugo N, Bukusi E, Katabira E, Asiimwe S, Thomas KK, Celum C, Baeten JM.

J Int AIDS Soc. 2017 Jul 25;20(1):21842. doi: 10.7448/IAS.20.1.21842. Erratum in: J Int AIDS Soc. 2017 Dec;20(4):.

48.

Efficacy of oral pre-exposure prophylaxis (PrEP) for HIV among women with abnormal vaginal microbiota: a post-hoc analysis of the randomised, placebo-controlled Partners PrEP Study.

Heffron R, McClelland RS, Balkus JE, Celum C, Cohen CR, Mugo N, Bukusi E, Donnell D, Lingappa J, Kiarie J, Fiedler T, Munch M, Fredricks DN, Baeten JM; Partners PrEP Study Team.

Lancet HIV. 2017 Oct;4(10):e449-e456. doi: 10.1016/S2352-3018(17)30110-8. Epub 2017 Jul 18.

49.

Highly conserved intragenic HSV-2 sequences: Results from next-generation sequencing of HSV-2 UL and US regions from genital swabs collected from 3 continents.

Johnston C, Magaret A, Roychoudhury P, Greninger AL, Cheng A, Diem K, Fitzgibbon MP, Huang ML, Selke S, Lingappa JR, Celum C, Jerome KR, Wald A, Koelle DM.

Virology. 2017 Oct;510:90-98. doi: 10.1016/j.virol.2017.06.031. Epub 2017 Jul 13.

50.

The effect of oral preexposure prophylaxis on the progression of HIV-1 seroconversion.

Donnell D, Ramos E, Celum C, Baeten J, Dragavon J, Tappero J, Lingappa JR, Ronald A, Fife K, Coombs RW; Partners PrEP Study Team.

AIDS. 2017 Sep 10;31(14):2007-2016. doi: 10.1097/QAD.0000000000001577.

Supplemental Content

Support Center